Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing
- PMID: 39744190
- PMCID: PMC11686545
- DOI: 10.4254/wjh.v16.i12.1441
Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing
Abstract
Background: The incidence of Klebsiella pneumoniae (K. pneumoniae) infection in patients with cirrhosis has been increasing over recent years, posing certain difficulties in clinical treatment.
Aim: To analyze the clinical features of patients with liver cirrhosis and identify the risk factors to help the early diagnosis and treatment of these diseases.
Methods: Clinical data and laboratory tests were collected from 72 patients with cirrhosis confirmed by secretion or blood culture of K. pneumoniae infection at Beijing Ditan Hospital, Capital Medical University, between May 2016 and October 2018. Data from hospitalized patients with liver cirrhosis and K. pneumoniae infections, including age, sex, antimicrobial use, length of stay, site of infection, distribution of pathogenic bacteria, complications, invasive operations, laboratory indicators, treatment, and clinical regression, were extracted and retrospectively analyzed. Clinical data and biochemical values were included in the multivariate logistic regression analysis.
Results: A total of 52 men and 20 women, with an age range from 29 to 85 years and an average age of 57.7 ± 12.54, were analyzed. The incidence of hospital K. pneumoniae infection in patients with cirrhosis was approximately 19.44%. The most common the infection site was the bloodstream, followed by the respiratory tract, abdominal cavity, and biliary tract. Risk factors for infection were old age, long hospital stays, gastrointestinal bleeding, and low serum albumin levels, while prophylactic antibiotics were protective factors. The multivariate analysis suggested that other infections, chronic diseases, and invasive procedures were independent factors.
Conclusion: In clinical practice, the length of hospital stays should be shortened as much as possible, invasive operations should be reduced, antibiotics should be rationally used, and the patients' liver function should be timely improved. This is of great significance for reducing the incidence of hospital infection.
Keywords: Antibiotics; Cirrhosis; Hospital infection; Klebsiella pneumoniae; Logistic regression.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Similar articles
-
[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Nov;32(11):1324-1330. doi: 10.3760/cma.j.cn121430-20200601-00431. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463491 Chinese.
-
Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections.Eur J Pediatr. 2020 Nov;179(11):1689-1698. doi: 10.1007/s00431-020-03675-8. Epub 2020 May 11. Eur J Pediatr. 2020. PMID: 32394266
-
[Clinical characteristics of 500 hospitalized patients with liver cirrhosis: a retrospective analysis from a tertiary hospital in Beijing].Zhonghua Gan Zang Bing Za Zhi. 2022 May 20;30(5):541-545. doi: 10.3760/cma.j.cn501113-20201126-00631. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 35764547 Chinese.
-
[Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].Mikrobiyol Bul. 2020 Jul;54(3):378-391. doi: 10.5578/mb.69679. Mikrobiyol Bul. 2020. PMID: 32755515 Turkish.
-
The risk factors for complications and survival outcomes of Klebsiella pneumoniae Bacteraemia in Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia.Med J Malaysia. 2022 Jul;77(4):440-445. Med J Malaysia. 2022. PMID: 35902933
Cited by
-
Clinical features and risk factors for combined Klebsiella pneumoniae infection in patients with liver cirrhosis.World J Hepatol. 2025 Feb 27;17(2):103648. doi: 10.4254/wjh.v17.i2.103648. World J Hepatol. 2025. PMID: 40027572 Free PMC article.
References
-
- Yardeni D, Ghany MG. Review article: hepatitis B-current and emerging therapies. Aliment Pharmacol Ther. 2022;55:805–819. - PubMed
-
- Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P International Club of Ascites Global Study Group. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. J Hepatol. 2021;74:330–339. - PubMed
LinkOut - more resources
Full Text Sources